Eam Global Investors LLC Bridge Bio Pharma, Inc. Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$24.02 - $43.89 $561,395 - $1.03 Million
-23,372 Reduced 16.52%
118,138 $4.77 Million
Q3 2023

Nov 13, 2023
SELL
$16.89 - $35.01 $1.38 Million - $2.86 Million
-81,724 Reduced 36.61%
141,510 $3.73 Million
Q1 2023

May 12, 2023
BUY
$7.17 - $18.55 $1.6 Million - $4.14 Million
223,234 New
223,234 $3.7 Million

Others Institutions Holding BBIO

# of Institutions
290
Shares Held
170M
Call Options Held
10.4M
Put Options Held
2.37M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email